Document quand l'auteur est "Bell, John Cameron"

Carter-Timofte, Madalina Elena; Arulanandam, Rozanne; Kurmasheva, Naziia; Fu, Kathy; Laroche, Geneviève; Taha, Zaid; van der Horst, Demi; Cassin, Lena; van der Sluis, Renée M; Palermo, Enrico; Di Carlo, Daniele; Jacobs, David; Maznyi, Glib; Azad, Taha; Singaravelu, Ragunath; Ren, Fanghui; Hansen, Anne Louise; Idorn, Manja; Holm, Christian K; Jakobsen, Martin R; van Grevenynghe, Julien ORCID: https://orcid.org/0000-0002-2952-4081; Hiscott, John; Paludan, Søren R; Bell, John Cameron; Séguin, Jean R.; Sabourin, Luc A; Côté, Marceline; Diallo, Jean-Simon; Alain, Tommy et Olagnier, David (2021). Antiviral Potential of the Antimicrobial Drug Atovaquone against SARS-CoV-2 and Emerging Variants of Concern ACS Infectious Diseases , vol. 7 , nº 11. pp. 3034-3051. DOI: 10.1021/acsinfecdis.1c00278.

Zakaria, Chadi; Sean, Polen; Hoang, Huy-Dung; Leroux, Louis-Phillipe; Watson, Margaret; Tekeste Workenhe, Samuel; Hearnden, Jaclyn; Pearl, Dana; Truong, Vinh Tai; Robichaud, Nathaniel; Yanagiya, Akiko; Tahmasebi, Soroush; Jafarnejad, Seyed Mehdi; Jia, Jian-Jun; Pelin, Adrian; Diallo, Jean-Simon; Le Boeuf, Fabrice; Bell, John Cameron; Mossman, Karen Louise; Graber, Tyson; Jaramillo, Maritza ORCID: https://orcid.org/0000-0002-1910-5684; Sonenberg, Nahum et Alain, Tommy (2018). Active-site mTOR inhibitors augment HSV1-dICP0 infection in cancer cells via dysregulated eIF4E/4E-BP axis PLoS Pathogens , vol. 14 , nº 8:e1007264. pp. 1-23. DOI: 10.1371/journal.ppat.1007264.